Imaging Technology

SEPTEMBER 12, 2023

Zelefsky brings an unparalleled level of expertise and leadership that will further elevate our team at Perlmutter Cancer Center,” said Alec Kimmelman, MD, PhD , the Anita Steckler and Joseph Steckler Chair of the Department of Radiation Oncology. milla1cf Tue, 09/12/2023 - 13:16 September 12, 2023 — Michael J.

Radiation 97

Radiation Radiation Oncology PET Scan Clinic 97

AuntMinnie

MARCH 26, 2024

Food and Drug Administration's (FDA) approvals of radiopharmaceuticals for neuroendocrine tumors and then for prostate cancer, theranostics has picked up momentum in clinical practice, propelled by encouraging research. After binding to the receptor, the drug works by entering the cell allowing radiation to cause damage to the tumor cells.

Nuclear Medicine 122

Nuclear Medicine Radiopharmaceuticals Radiation Health Science 122

AuntMinnie

JUNE 20, 2024

Food and Drug Administration's (FDA) approvals of radiopharmaceuticals for neuroendocrine tumors and then for prostate cancer, theranostics has picked up momentum in clinical practice, propelled by encouraging research. After binding to the receptor, the drug works by entering the cell allowing radiation to cause damage to the tumor cells.

Nuclear Medicine 52

Nuclear Medicine Radiopharmaceuticals Radiation Health Science 52

Imaging Technology

SEPTEMBER 19, 2023

milla1cf Tue, 09/19/2023 - 13:47 September 19, 20223 — RefleXion Medical, a therapeutic oncology company, announced the company will showcase the RefleXion X1 with SCINTIX biology-guided radiotherapy at the American Society for Radiation Oncology ( ASTRO ) Annual Meeting, Oct. 1-4, 2023 in San Diego, BOOTH # 2831.

Radiation Oncology 52

Radiation Oncology PET Scan Radiation Medical 52